Sjoerd H. Hofma

2018 ESC/EACTS Guidelines on myocardial revascularization

Franz‐Josef Neumann, Miguel Sousa‐Uva, Anders Ahlsson et al. · European Heart Journal · 2018 · 7.1K citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 785 citations · Full text

Medicine, Cardiology, Pharmacotherapy +16

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

Patrick W. Serruys, Sigmund Silber, Scot Garg et al. · New England Journal of Medicine · 2010 · 664 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Unrestricted Utilization of Sirolimus-Eluting Stents Compared With Conventional Bare Stent Implantation in the “Real World”

Pedro A. Lemos, Patrick W. Serruys, Ron T. van Domburg et al. · Circulation · 2003 · 544 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +11

Bioresorbable Scaffolds versus Metallic Stents in Routine PCI

Joanna J. Wykrzykowska, Robin P. Kraak, Sjoerd H. Hofma et al. · New England Journal of Medicine · 2017 · 435 citations · Full text

Medicine, Cardiology, Cardiovascular Pharmacotherapy +16